What is Zacks Research’s Estimate for Westlake Q1 Earnings?

Westlake Co. (NYSE:WLK) – Equities research analysts at Zacks Research decreased their Q1 2026 EPS estimates for Westlake in a research note issued on Thursday, March 13th. Zacks Research analyst R. Department now anticipates that the specialty chemicals company will post earnings of $2.05 per share for the quarter, down from their previous forecast of $2.20. The consensus estimate for Westlake’s current full-year earnings is $6.48 per share. Zacks Research also issued estimates for Westlake’s Q3 2026 earnings at $2.33 EPS and FY2027 earnings at $8.02 EPS.

A number of other research analysts also recently issued reports on the company. Barclays cut their price target on Westlake from $175.00 to $135.00 and set an “overweight” rating on the stock in a report on Tuesday, February 25th. Morgan Stanley decreased their price target on shares of Westlake from $130.00 to $122.00 and set an “equal weight” rating for the company in a report on Wednesday, February 26th. JPMorgan Chase & Co. upgraded Westlake from an “underweight” rating to a “neutral” rating and dropped their target price for the company from $135.00 to $110.00 in a research report on Thursday, February 27th. Piper Sandler cut their price target on Westlake from $155.00 to $135.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 7th. Finally, Truist Financial lowered their price objective on Westlake from $168.00 to $166.00 and set a “buy” rating on the stock in a research report on Tuesday, February 25th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $140.07.

Westlake Stock Up 1.6 %

Shares of NYSE:WLK opened at $107.39 on Monday. The business has a 50 day simple moving average of $112.81 and a two-hundred day simple moving average of $125.54. The firm has a market capitalization of $13.77 billion, a PE ratio of 151.25, a price-to-earnings-growth ratio of 2.36 and a beta of 1.18. Westlake has a 1 year low of $104.74 and a 1 year high of $162.64. The company has a debt-to-equity ratio of 0.41, a current ratio of 2.79 and a quick ratio of 2.04.

Westlake (NYSE:WLK) last announced its quarterly earnings results on Monday, February 24th. The specialty chemicals company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $1.04 by ($0.98). The business had revenue of $2.84 billion during the quarter, compared to the consensus estimate of $3.01 billion. Westlake had a return on equity of 6.93% and a net margin of 0.81%. The company’s revenue for the quarter was up .6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.72 EPS.

Westlake Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, March 19th. Stockholders of record on Tuesday, March 4th will be issued a $0.525 dividend. The ex-dividend date is Tuesday, March 4th. This represents a $2.10 dividend on an annualized basis and a dividend yield of 1.96%. Westlake’s payout ratio is 45.36%.

Institutional Trading of Westlake

A number of hedge funds have recently added to or reduced their stakes in WLK. Crossmark Global Holdings Inc. lifted its position in shares of Westlake by 28.5% during the 3rd quarter. Crossmark Global Holdings Inc. now owns 2,898 shares of the specialty chemicals company’s stock valued at $436,000 after acquiring an additional 643 shares during the period. GSA Capital Partners LLP acquired a new position in shares of Westlake during the 3rd quarter valued at about $420,000. Sumitomo Mitsui Trust Group Inc. boosted its position in shares of Westlake by 1.9% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 80,568 shares of the specialty chemicals company’s stock worth $12,109,000 after acquiring an additional 1,491 shares during the last quarter. Oppenheimer & Co. Inc. grew its holdings in Westlake by 3.8% in the third quarter. Oppenheimer & Co. Inc. now owns 2,624 shares of the specialty chemicals company’s stock valued at $394,000 after purchasing an additional 97 shares during the period. Finally, KBC Group NV increased its position in Westlake by 1.4% during the third quarter. KBC Group NV now owns 26,548 shares of the specialty chemicals company’s stock worth $3,990,000 after purchasing an additional 358 shares during the last quarter. 28.40% of the stock is owned by institutional investors and hedge funds.

Westlake Company Profile

Westlake Corporation engages in the manufacture and marketing of performance and essential materials, and housing and infrastructure products in the United States, Canada, Germany, China, Mexico, Brazil, France, Italy, Taiwan, and internationally. The company operates through two segments: Performance and Essential Materials and Housing and Infrastructure Products.